G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GTHX G1 Therapeutics Inc.

休市中 05-17 16:00:00 EDT

4.53

-0.15

-3.21%

盘后4.53

+0.000.00%

19:46 EDT

最高4.69	最低4.50	成交量59.03万
今开4.68	昨收4.68	日振幅4.17%
总市值2.37亿	流通市值1.99亿	总股本5,228万
成交额269.73万	换手率1.34%	流通股本4,393万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GTHX","market":"US","secType":"STK","nameCN":"G1 Therapeutics Inc.","latestPrice":4.53,"timestamp":1715976000000,"preClose":4.68,"halted":0,"volume":590258,"hourTrading":{"tag":"盘后","latestPrice":4.53,"preClose":4.53,"latestTime":"19:46 EDT","volume":492,"amount":2246.5479,"timestamp":1715989599647},"delay":0,"floatShares":43930223,"shares":52281391,"eps":-0.592624,"marketStatus":"休市中","marketStatusCode":7,"change":-0.15,"latestTime":"05-17 16:00:00 EDT","open":4.68,"high":4.69,"low":4.495,"amount":2697285.8095307997,"amplitude":0.041667,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.592624,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716192000000},"adr":0,"listingDate":1494993600000,"adjPreClose":4.68,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.68,"preClose":4.68,"latestTime":"09:29 EDT","volume":1186,"amount":5572.224124,"timestamp":1715952599914},"postHourTrading":{"tag":"盘后","latestPrice":4.53,"preClose":4.53,"latestTime":"19:46 EDT","volume":492,"amount":2246.5479,"timestamp":1715989599647},"volumeRatio":0.5834195065723263},"requestUrl":"/m/hq/s/GTHX/","defaultTab":"news","newsList":[{"id":"2433434369","title":"G1 Therapeutics, Inc.2024财年第一财季实现净利润-10.22百万美元，同比增加62.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433434369","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433434369?lang=zh_cn&edition=full","pubTime":"2024-05-06 00:19","pubTimestamp":1714925977,"startTime":"0","endTime":"0","summary":"3月31日，G1 Therapeutics, Inc.公布财报，公告显示公司2024财年第一财季净利润为-10.22百万美元，同比增加62.97%；其中营业收入为14.48百万美元，同比增加11.81%，每股基本收益为-0.20美元。机构评级：截至2024年3月31日，当前有4家机构对G1 Therapeutics, Inc.目标价做出预测，其中目标均价为8.50美元，其中最低目标价为5.00美元，最高目标价为12.00美元。公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050600194687d52a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050600194687d52a16&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431866589","title":"G1 Therapeutics, Inc.盘中异动 股价大跌5.01%报3.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431866589","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431866589?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:44","pubTimestamp":1714398252,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时44分，G1 Therapeutics, Inc.股票出现波动，股价大幅跳水5.01%。截至发稿，该股报3.79美元/股，成交量8.2342万股，换手率0.16%，振幅5.01%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Immunitybio, Inc.、Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为615.51%、27.66%、14.27%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Immunitybio, Inc.、Eliem Therapeutics, Inc，振幅分别为33.33%、20.98%、18.59%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921441287e84bf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921441287e84bf0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431486867","title":"G1 Therapeutics Inc   预计每股亏损21美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431486867","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431486867?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:21","pubTimestamp":1714396915,"startTime":"0","endTime":"0","summary":"   * G1 Therapeutics Inc    预计将在5月1日公布截至2024年3月31日的季度收入报告。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于北卡罗来纳州三角研究园的公司的营收有望从去年同期的1295万美元增长17.9%，达到1525.9万美元。* LSEG 分析师对 G1 Therapeutics Inc 的平均预期是每股亏损 21 美分。* 华尔街对 G1 Therapeutics Inc 的 12 个月目标价中位数为 8.50 美元，高于其上次收盘价 3.99 美元。4月29日 - 以往季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429118955","title":"G1 Therapeutics, Inc.盘中异动 股价大涨5.24%报4.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118955","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429118955?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:54","pubTimestamp":1713880488,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时54分，G1 Therapeutics, Inc.股票出现波动，股价急速上涨5.24%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Palisade Bio, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cyclacel Pharmaceuticals Inc 6% Cnv Pfd Usd涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为1478.10%、165.91%、26.03%，振幅较大的相关个股有Palisade Bio, Inc.、Immunitybio, Inc.、Moolec Science Sa C/Wts ，振幅分别为32.86%、25.10%、23.24%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232154487a54eea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232154487a54eea6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428345662","title":"G1 Therapeutics, Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428345662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428345662?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:36","pubTimestamp":1713360965,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时36分，G1 Therapeutics, Inc.股票出现波动，股价大幅上涨5.15%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Psyence Biomedical Ltd C/Wts 25/01/2029、Vanda Pharmaceuticals Inc.涨幅较大，Clearmind Medicine Inc.、Novabay Pharmaceuticals, Inc.、Longeveron Inc.较为活跃，换手率分别为25.54%、22.73%、20.12%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Jaguar Health, Inc.、Viracta Therapeutics, Inc.，振幅分别为25.30%、16.55%、15.75%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721360579214110&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041721360579214110&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427873061","title":"G1 Therapeutics, Inc.盘中异动 快速下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427873061","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427873061?lang=zh_cn&edition=full","pubTime":"2024-04-13 00:32","pubTimestamp":1712939567,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日00时32分，G1 Therapeutics, Inc.股票出现异动，股价大幅跳水5.02%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。该信息摘要如下：Needham：重申G1 Therapeutics评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300324787e7ffeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300324787e7ffeb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426204497","title":"Needham：重申G1 Therapeutics(GTHX.US)评级，由买入调整至买入评级, 目标价12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426204497","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426204497?lang=zh_cn&edition=full","pubTime":"2024-04-12 18:05","pubTimestamp":1712916349,"startTime":"0","endTime":"0","summary":"Needham：重申G1 Therapeutics(GTHX.US)评级，由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412180554876e3e6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412180554876e3e6c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422615339","title":"G1 Therapeutics, Inc.盘中异动 急速上涨5.07%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422615339","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422615339?lang=zh_cn&edition=full","pubTime":"2024-03-26 21:40","pubTimestamp":1711460404,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日21时40分，G1 Therapeutics, Inc.股票出现波动，股价急速上涨5.07%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Stoke Therapeutics, Inc.、Abvc Biopharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Abvc Biopharma, Inc.、Stoke Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为123.88%、18.80%、13.24%，振幅较大的相关个股有Stoke Therapeutics, Inc.、Bio-Path Holdings, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为29.69%、21.43%、16.01%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326214005861e1404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240326214005861e1404&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421819424","title":"G1 Therapeutics, Inc.盘中异动 早盘大幅上涨6.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421819424","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421819424?lang=zh_cn&edition=full","pubTime":"2024-03-22 21:32","pubTimestamp":1711114374,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日21时32分，G1 Therapeutics, Inc.股票出现异动，股价大幅上涨6.21%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Gt Biopharma, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Matinas Biopharma Holdings, Inc.涨幅较大，Okyo Pharma Ltd Com Npv 、Revelation Biosciences, Inc.、Nutriband Inc.较为活跃，换手率分别为4.78%、3.60%、3.35%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Nkarta, Inc.、Xtl生物制药，振幅分别为32.68%、11.71%、10.74%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221325487e7b0d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032221325487e7b0d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421774766","title":"G1 Therapeutics, Inc.盘中异动 急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421774766","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421774766?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:33","pubTimestamp":1710959598,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时33分，G1 Therapeutics, Inc.股票出现异动，股价急速拉升5.03%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Xtl生物制药、Surrozen Inc C/Wts 01/08/2031 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为209.88%、87.11%、46.58%，振幅较大的相关个股有Xtl生物制药、Nls Pharmaceutics Ltd.、Igc Pharma, Inc.，振幅分别为157.69%、66.78%、43.55%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321023318791bc400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321023318791bc400&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420276755","title":"G1 Therapeutics, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420276755","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420276755?lang=zh_cn&edition=full","pubTime":"2024-03-19 23:02","pubTimestamp":1710860557,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日23时02分，G1 Therapeutics, Inc.股票出现波动，股价大幅上涨5.14%。截至发稿，该股报3.38美元/股，成交量21.4778万股，换手率0.41%，振幅7.01%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、知临集团涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为825.61%、406.53%、136.03%，振幅较大的相关个股有Enveric Biosciences, Inc.、知临集团、Tracon Pharmaceuticals, Inc.，振幅分别为55.45%、49.87%、47.94%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192302377a4db743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192302377a4db743&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419021076","title":"G1 Therapeutics, Inc.盘中异动 股价大跌5.20%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419021076","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419021076?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:48","pubTimestamp":1710424112,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时48分，G1 Therapeutics, Inc.股票出现波动，股价急速下跌5.20%。G1 Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，知临集团、Revolution Medicines Inc C/Wts 17/12/2026 、Nutriband Inc C/Wts 涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为155.04%、131.65%、65.19%，振幅较大的相关个股有知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.，振幅分别为65.13%、40.32%、38.38%。G1 Therapeutics, Inc.公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214833791a7c66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214833791a7c66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416000906","title":"G1 Therapeutics, Inc.2023财年实现净利润-47.97百万美元，同比增加67.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416000906","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416000906?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:17","pubTimestamp":1709482657,"startTime":"0","endTime":"0","summary":"12月31日，G1 Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为-47.97百万美元，同比增加67.59%；其中营业收入为82.51百万美元，同比增加60.84%，每股基本收益为-0.93美元。机构评级：截至2023年12月31日，当前有4家机构对G1 Therapeutics, Inc.目标价做出预测，其中目标均价为8.50美元，其中最低目标价为5.00美元，最高目标价为12.00美元。公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040017448afdd0eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403040017448afdd0eb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414082178","title":"G1 Therapeutics In盘中异动 早盘急速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414082178","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414082178?lang=zh_cn&edition=full","pubTime":"2024-02-27 22:32","pubTimestamp":1709044331,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日22时32分，G1 Therapeutics In股票出现异动，股价大幅上涨5.22%。截至发稿，该股报2.42美元/股，成交量3.2497万股，换手率0.06%，振幅3.48%。G1 Therapeutics In股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Janux Therapeutics Inc、Viking Therapeutics Inc、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Scisparc Ltd、Zyversa Therapeutics Inc、Galera Therapeutics Inc较为活跃，换手率分别为309.71%、83.86%、29.61%，振幅较大的相关个股有Viking Therapeutics Inc、Fate Therapeutics、Janux Therapeutics Inc，振幅分别为21.70%、17.84%、14.57%。G1 Therapeutics In公司简介：G1 Therapeutics Inc 是一家商业阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272232127a4752e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402272232127a4752e7&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.g1therapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0503},{"period":"1month","weight":0.0584},{"period":"3month","weight":0.9034},{"period":"6month","weight":1.8854},{"period":"1year","weight":0.6295},{"period":"ytd","weight":0.4852}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"G1 Therapeutics, Inc.于2008年5月19日以“G-Zero Therapeutics, Inc.”的名义，以特拉华州的法律注册成立。2012年9月，他们更名为“G1治疗公司”。该公司是一家商业化阶段的生物制药公司，专注于开发和商业化治疗癌症患者的新型小分子疗法。美国食品和药物管理局批准的第一个产品COSELA（trilaciclib）是第一个也是唯一一个被证明可以主动帮助保护骨髓免受化疗（骨髓保护）损害的疗法，也是几十年来管理骨髓保护的第一个创新。2022年7月，COSELA（注射用盐酸曲拉西利布）获国家药品监督管理局有条件批准在中国上市。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.163982},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.143278},{"month":3,"riseRate":0.428571,"avgChangeRate":0.000021},{"month":4,"riseRate":0.571429,"avgChangeRate":0.00162},{"month":5,"riseRate":0.571429,"avgChangeRate":0.066317},{"month":6,"riseRate":0.714286,"avgChangeRate":0.122249},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.021365},{"month":8,"riseRate":0.714286,"avgChangeRate":0.189478},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.118075},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.046198},{"month":11,"riseRate":0.428571,"avgChangeRate":0.013336},{"month":12,"riseRate":0.285714,"avgChangeRate":0.000011}],"exchange":"NASDAQ","name":"G1 Therapeutics Inc.","nameEN":"G1 Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供G1 Therapeutics Inc.(GTHX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"G1 Therapeutics Inc.,GTHX,G1 Therapeutics Inc.股票,G1 Therapeutics Inc.股票老虎,G1 Therapeutics Inc.股票老虎国际,G1 Therapeutics Inc.行情,G1 Therapeutics Inc.股票行情,G1 Therapeutics Inc.股价,G1 Therapeutics Inc.股市,G1 Therapeutics Inc.股票价格,G1 Therapeutics Inc.股票交易,G1 Therapeutics Inc.股票购买,G1 Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"G1 Therapeutics Inc.(GTHX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供G1 Therapeutics Inc.(GTHX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}